Form D · Biotechnology
Insilico Medicine, Inc.
Rockville, MD · CIK 0001698493
Offering snapshot reported Jun 18, 2018 · SEC filing
- Reported sold
- $6M Offering amount: $6M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 1, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 18, 2018 | Initial | $5,999,950 | No comparison | 15 | SEC filing |
| Jul 18, 2017 | Amendment | $2,759,489 | -$7,239,499vs Feb 22, 2017 | 17 | SEC filing |
| Jul 18, 2017 | Initial | $4,000,000 | No comparison | 1 | SEC filing |
| Feb 22, 2017 | Initial | $9,998,988 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-314770
Source: Form D, filed Jun 18, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Mellon | Director |
| Aleksandrs Zavoronkovs | Director, Executive |
| Alex Zhavoronkov | Director, Executive |
| Qingsong Zhu | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9601 Medical Center Dr, Suite 127
Rockville, MD, 20850
Rockville, MD, 20850